Zimbabwe: Govt to Roll Out Twice-Yearly HIV Injection in Major Prevention Push

Zimbabwe is preparing to place at least 46 500 people on a long-acting HIV prevention drug early next year marking the country’s first rollout of Lenacapavir a twice-yearly injectable that offers sustained protection against HIV.

Health officials say the introduction of Lenacapavir represents a major shift in the country’s HIV prevention strategy replacing the need for daily pills with a single injection that provides protection for six months.

The drug is expected to address long-standing…